Literature DB >> 8939949

Regulation of cyclooxygenases by protein kinase C. Evidence against the importance of direct enzyme phosphorylation.

R Vezza1, A Habib, H Li, J A Lawson, G A FitzGerald.   

Abstract

Cyclooxygenases (COXs) are key prostaglandin biosynthetic enzymes. While COX-1 expression is largely constitutive, COX-2 is highly regulated by cytokines, growth factors, and tumor promoters, such as the protein kinase C (PKC) activator, phorbol 12-myristate 13-acetate (PMA). While phosphorylation of transcription factors may regulate COX transcription, the existence of PKC consensus sequences suggests that direct enzyme phosphorylation might also regulate differential expression of the enzymes. Nevertheless, phosphorylation of both human recombinant COX-1 and COX-2 by rat brain PKC in vitro was minimal, as was phosphorylation of peptides based on PKC consensus sequences in COX-1 (less than 4% of the phosphorylation of the PKC-alpha pseudosubstrate peptide). Similarly, phosphorylation of the corresponding COX-2 peptides was not observed using either the phosphocellulose paper absorption method or electrospray mass spectrometry. MEG-01 and NIH 3T3 cells were labeled with [32P]orthophosphate to investigate COX phosphorylation in vivo. COX-2 synthesis was induced by PMA (100 nM) or serum stimulation in NIH 3T3 cells. COX-1 was expressed constitutively in MEG-01 cells. Specific polyclonal antibodies raised against sequences of human COX-1 (Ala24-Cys35) and COX-2 (Asn580-Lys598) were used for immunoprecipitation. Neither COX-1 nor COX-2 was phosphorylated in vivo, irrespective of the presence of a phosphatase inhibitor (1 microM okadaic acid). Although COX-1 and COX-2 are differentially regulated, no differences were observed in terms of susceptibility to phosphorylation by PKC either in vitro or in vivo. Despite regulated expression of COX-2 by PMA and the existence of consensus sequences for PKC phosphorylation, it appears that it is an unfavorable substrate for this enzyme.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8939949     DOI: 10.1074/jbc.271.47.30028

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Protein kinase Cα deletion causes hypotension and decreased vascular contractility.

Authors:  Brandi M Wynne; Cameron G McCarthy; Theodora Szasz; Patrick A Molina; Arlene B Chapman; R Clinton Webb; Janet D Klein; Robert S Hoover
Journal:  J Hypertens       Date:  2018-03       Impact factor: 4.844

Review 2.  Cyclooxygenase 2: protein-protein interactions and posttranslational modifications.

Authors:  Anna Alexanian; Andrey Sorokin
Journal:  Physiol Genomics       Date:  2017-09-22       Impact factor: 3.107

Review 3.  Cyclooxygenase-2 modulates cellular growth and promotes tumorigenesis.

Authors:  O C Trifan; T Hla
Journal:  J Cell Mol Med       Date:  2003 Jul-Sep       Impact factor: 5.310

4.  Post-translational regulation of COX2 activity by FYN in prostate cancer cells.

Authors:  Anna Alexanian; Bradley Miller; Marla Chesnik; Shama Mirza; Andrey Sorokin
Journal:  Oncotarget       Date:  2014-06-30

Review 5.  The relevance of piroxicam for the prevention and treatment of nonmelanoma skin cancer and its precursors.

Authors:  Elena Campione; Evelin Jasmine Paternò; Eleonora Candi; Mattia Falconi; Gaetana Costanza; Laura Diluvio; Alessandro Terrinoni; Luca Bianchi; Augusto Orlandi
Journal:  Drug Des Devel Ther       Date:  2015-10-29       Impact factor: 4.162

6.  Autocrine regulation of airway smooth muscle contraction by diacylglycerol kinase.

Authors:  Santosh K Yadav; Pawan Sharma; Sushrut D Shah; Reynold A Panettieri; Taku Kambayashi; Raymond B Penn; Deepak A Deshpande
Journal:  J Cell Physiol       Date:  2021-07-18       Impact factor: 6.513

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.